Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical is a major subsidiary and core manufacturing base of Chia Tai Tianqing Pharmaceutical Group (CTTQ), one of China's largest and most innovative pharmaceutical companies. Located in Nanjing, the company operates advanced GMP-certified facilities dedicated to the production of high-end generics and innovative biologics and small molecules. Its therapeutic focus aligns with the parent group's strengths in oncology, liver disease, respiratory health, and infectious diseases. As a critical arm of the Sino Biopharmaceutical network, Nanjing Shunxin plays a vital role in scaling up R&D successes into commercial-grade treatments for the Chinese and global markets. The company is instrumental in the production of flagship products such as the multi-target kinase inhibitor anlotinib.